| Genentech, Inc. |
|
Genentech, Inc., is a biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Fourteen of the currently approved biotechnology products stem from Genentech science. Genentech markets nine biotechnology products directly in the United States.
Submitted: Nov 15, 2000
|
| Ariad |
|
ARIAD Pharmaceuticals is specialized in the discovery and development of proprietary platform technologies and small-molecule therapeutic products based on gene regulation and signal transduction.
Submitted: Nov 14, 2000
|
| Berlex Laboratories, Inc. |
|
Committed to bringing to the market preventive, diagnostic and therapeutic medicines in the fields of dermatology, diagnostic imaging, women’s health and therapeutics.
Submitted: Nov 14, 2000
|
| Biopure |
|
Biopure Corporation (Nasdaq: BPUR) is a developer, manufacturer and marketer of a new class of intravenous solutions, called "oxygen therapeutics," that sustain blood volume and deliver oxygen to the body's tissues. Biopure's oxygen therapeutics possess unique attributes that address many of the medical, logistical and economic issues associated with red blood cell transfusions. The company operates a manufacturing facility with the capacity to produce its FDA-approved veterinary product for commercial sale and a similar, investigational product for human clinical trials and market introduction following regulatory approval.
Submitted: Nov 14, 2000
|
| Cambridge Drug Discovery |
|
Innovative biological solutions for discovery in pharmaceutical, agrochemical and biotechnology industries.
Submitted: Nov 13, 2000
|
| CTI |
|
Cell Therapeutics, Inc. is focused on developing, acquiring, and commercializing therapies to combat the disease without compromising patient quality of life.
Submitted: Nov 15, 2000
|
| diaDexus |
|
diaDexus is a genomics company dedicated to the discovery and development of novel genomic biomarkers for the detection and treatment of disease. The Company is developing novel, genomically derived products to detect the early onset of disease, select the most appropriate patient-specific therapeutic regimen and predict and monitor patient response to therapy. Further, the Company is planning to utilize its patented genomic biomarkers to develop novel therapeutic monoclonal antibodies and therapeutic vaccines.
Submitted: Nov 15, 2000
|
| Draxis Health Inc. |
|
DRAXIS Health Inc. is an emerging Canadian pharmaceutical company with four operating business units. The Veterinary Pharmaceutical Unit (operating under the name Deprenyl Animal Health, Inc.) researches, develops, markets and sells prescription pharmaceuticals for companion animals. The Dermatology Pharmaceutical Unit (operating under the name SpectroPharm Dermatology) researches, markets and sells prescription and non-prescription dermatologicals, including podiatrics, in Canada and the United States. The Canadian Pharmaceutical Marketing Unit (operating under the name DRAXIS Pharmaceutica) markets and sells in Canada prescription pharmaceuticals specializing in the field of neurological disease. The Radiopharmaceutical Unit (operating under the name DRAXIMAGE Inc.) is engaged in the research, development, manufacture, marketing and sale of radiopharmaceuticals for diagnostic and therapeutic purposes.
Submitted: Nov 15, 2000
|
| Euroscreen |
|
Recombinant Cellular Receptors for the Pharmaceutical and Biomedical Industries.
Submitted: Nov 13, 2000
|
| Genzyme Corporation |
|
A highly diversified biotechnology company, Genzyme uses a wide range of technologies to provide 900 human health care products and services. The company has extensive capabilities in biotechnology sales and marketing, manufacturing, research and development, and other disciplines necessary for success in the health care market.
Submitted: Nov 15, 2000
|
| Morphochem |
|
Morphochem is a drug discovery company focused on finding new therapeutic agents to treat diseases where there is an unmet clinical need.
Submitted: Nov 14, 2000
|
| Novalon |
|
Novalon is specialized in the field of genomics-based drug discovery. Novalon is creating a tremendous pipeline of novel pharmaceuticals through the company's technology access programs and therapeutic programs.
Submitted: Nov 14, 2000
|
| Organon |
|
A pharmaceutical company specialized in prescription medicine for gynaecology, psychiatry, immunology and athero-thrombosis.
Submitted: Nov 15, 2000
|
| Purdue Pharma |
|
Purdue Pharma L. P. is a research oriented pharmaceutical company which seeks to provide a benefit to patients by providing new and improved treatments for diseases and their symptoms. Purdue seeks to continually develop and sell new, high quality, innovative, pharmaceutical preparations, which together with clinical data and medical education create new value for patients and the health care system.
Submitted: Nov 15, 2000
|
| Rheogene |
|
RHeoGene is developing and applying enabling gene tools based initially on its proprietary ligand-driven gene switching technology. The ligand is one of a proprietary library of ecdysone analogues, and areas of application include human gene therapy and switch-driven cell-based assays for drug discovery.
Submitted: Nov 14, 2000
|
| SmithKline Beecham |
|
SmithKline Beecham (SBH/SB.) -- SB, a research-intensive company, develops prescription pharmaceuticals, vaccines, and consumer medicines.
Submitted: Nov 15, 2000
|
| Synsorb |
|
SYNSORB Biotech Inc. is a Canadian pharmaceutical company dedicated to drug development and manufacturing.
Submitted: Nov 15, 2000
|
| Third Wave Technologies |
|
Third Wave Technologies develops and commercializes simple, low-cost nucleic acid platform technologies to fundamentally alter disease discovery, diagnosis and treatment.
Submitted: Nov 14, 2000
|
| Allergan |
|
Allergan, Inc., headquartered in Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets that deliver value to our customers, satisfy unmet medical needs and improve patients' lives.
Submitted: Nov 14, 2000
|
| Amgen |
|
Amgen delivers important, cost-effective therapeutics based on advanced cellular and molecular biology.
Submitted: Nov 14, 2000
|
| Amylin Pharmaceuticals |
|
Amylin Pharmaceuticals, Inc. is engaged in the discovery and development of potential drug candidates for the treatment of metabolic disorders.
Submitted: Nov 14, 2000
|
| Angiotech Pharmaceuticals |
|
Angiotech Pharmaceuticals is a Canadian pharmaceutical company dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug, paclitaxel.
Submitted: Nov 14, 2000
|
| Antisoma |
|
Antisoma is a biopharmaceutical company developing novel products for the treatment of cancer.
Submitted: Nov 14, 2000
|
| Baxter Healthcare |
|
A global medical products and services company focusing on critical therapies for life-threatening conditions, specifically with products and services in blood therapies, cardiovascular medicine, medication delivery and renal therapy.
Submitted: Nov 14, 2000
|
| Chiron Corporation |
|
Chiron Corporation, headquartered in Emeryville, California, is a biotechnology company that participates in three global healthcare markets: biopharmaceuticals, blood testing and vaccines. The company is applying a broad and integrated scientific approach to the development of innovative products for preventing and treating cancer, infectious diseases, and cardiovascular diseases.
Submitted: Nov 15, 2000
|
| Dura Pharmaceuticals |
|
Dura Pharmaceuticals, Inc. is a San Diego based specialty pharmaceutical company that markets and sells prescription products that treat infectious and respiratory diseases.
Submitted: Nov 15, 2000
|
| EpiGenesis Pharmaceuticals Inc. |
|
Gene discovery in the respiratory tract, validation of candidate targets for respiratory drug discovery programs, and discovery and development of an array of traditional and molecular therapeutics for medically important respiratory diseases.
Submitted: Nov 13, 2000
|
| EpiVax |
|
EpiVax is dedicated to merging in vitro immunology research with bioinformatics to generate new vaccines for infectious diseases such as HIV, TB, and hepatitis, new therapeutics for cancer and auto-immune diseases, and new diagnostics for organ and marrow transplantation.
Submitted: Nov 13, 2000
|
| Genelabs |
|
Genelabs Technologies, Inc. is a global biopharmaceutical and diagnostics company focused on gene-regulating drug discovery; infectious diseases including hepatitis; and immunological disorders including lupus.
Submitted: Nov 15, 2000
|
| Gilead Sciences |
|
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.
Submitted: Nov 15, 2000
|
| GLYCODesign |
|
GLYCODesign is a biopharmaceutical company engaged in the discovery and early clinical development of small-molecule, orally-active therapeutics for the treatment of cancer, infectious diseases, chronic inflammation, and cardiovascular diseases. GLYCODesign is a world leader in glycobiology because of its innovative approach at treating disease with carbohydrate processing inhibitors (CPIs).
Submitted: Nov 15, 2000
|
| ImClone Systems Inc. |
|
ImClone Systems Incorporated is a publicly held biopharmaceutical company dedicated to the development of novel treatments for cancer and cancer-related disorders.
Submitted: Nov 15, 2000
|
| ImmunoScience, Inc. |
|
A biotechnology company manufacturing a superior quick saliva based test system for diagnosis of various conditions including HIV-1, HIV-2, hepatitis B & C, syphilis, TB and others. The company is also doing research on a very promising therapeutic vaccine leading to cure of HIV infection and AIDS.
Submitted: Nov 15, 2000
|
| Inpharmatica |
|
Inpharmatica has developed an unrivalled target discovery resource - the Biopendium™ - allowing pharmaceutical and biotechnology companies to identify and select novel drug targets or protein therapeutics from the proteome.
Submitted: Nov 13, 2000
|
| Lilly |
|
Eli Lilly and Company creates and delivers innovative medicines that enable people to live longer, healthier and more active lives. Lilly medicines treat depression, schizophrenia, diabetes, cancer, osteoporosis and many other diseases. They create value for patients, healthcare providers and payers, and reduce the cost of disease.
Submitted: Nov 15, 2000
|
| Micrologix Biotech Inc. |
|
Micrologix Biotech is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics to life-threatening diseases.
Submitted: Nov 15, 2000
|
| RepliGen Corporation |
|
Repligen Corporation is a biopharmaceutical company engaged in the discovery of novel therapeutics for autism, organ transplant and cancer. Repligen's products offer patients improved treatment options based on modulation of newly discovered disease mechanisms.
Submitted: Nov 14, 2000
|
| Trega Biosciences |
|
Trega Biosciences, Inc. is a premier provider of products that accelerate and improve drug discovery through its iDiscovery™ technologies linking biology and chemistry with information technologies.
Submitted: Nov 14, 2000
|
|
